Evidence map›Paper›PMID 34039343›Full record

ArticleBMC medical informatics and decision making2021

Investigating ADR mechanisms with Explainable AI: a feasibility study with knowledge graph mining.

Emmanuel Bresso, Pierre Monnin, Cédric Bousquet, François-Elie Calvier, Ndeye-Coumba Ndiaye, Nadine Petitpain, Malika Smaïl-Tabbone, Adrien Coulet

Open access · goldAbstract read
In one paragraph

Article in BMC medical informatics and decision making, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Emmanuel BressoUniversité de Lorraine, CNRS, Inria, LORIA, Nancy, France.
Pierre MonninUniversité de Lorraine, CNRS, Inria, LORIA, Nancy, France.
Cédric BousquetService de santé publique et information médicale, CHU de Saint Etienne, Saint Etienne, France.
François-Elie CalvierService de santé publique et information médicale, CHU de Saint Etienne, Saint Etienne, France.
Ndeye-Coumba NdiayeUniversité de Lorraine, Inserm U1256 - NGERE, Nancy, France.
Nadine PetitpainCentre Régional de Pharmacovigilance, CHRU of Nancy, Nancy, France.
Malika Smaïl-TabboneUniversité de Lorraine, CNRS, Inria, LORIA, Nancy, France.
Adrien CouletUniversité de Lorraine, CNRS, Inria, LORIA, Nancy, France. adrien.coulet@inria.fr.ORCID 0000-0002-1466-062X
Centre National de la Recherche Scientifique · FRInserm · FR

Funding

Agence Nationale de la Recherche 15-RHUS-0004Agence Nationale de la Recherche ANR-15-CE23-0028
6 · The paper itself

Abstract

backgroundAdverse drug reactions (ADRs) are statistically characterized within randomized clinical trials and postmarketing pharmacovigilance, but their molecular mechanism remains unknown in most cases. This is true even for hepatic or skin toxicities, which are classically monitored during drug design. Aside from clinical trials, many elements of knowledge about drug ingredients are available in open-access knowledge graphs, such as their properties, interactions, or involvements in pathways. In addition, drug classifications that label drugs as either causative or not for several ADRs, have been established.

methodsWe propose in this paper to mine knowledge graphs for identifying biomolecular features that may enable automatically reproducing expert classifications that distinguish drugs causative or not for a given type of ADR. In an Explainable AI perspective, we explore simple classification techniques such as Decision Trees and Classification Rules because they provide human-readable models, which explain the classification itself, but may also provide elements of explanation for molecular mechanisms behind ADRs. In summary, (1) we mine a knowledge graph for features; (2) we train classifiers at distinguishing, on the basis of extracted features, drugs associated or not with two commonly monitored ADRs: drug-induced liver injuries (DILI) and severe cutaneous adverse reactions (SCAR); (3) we isolate features that are both efficient in reproducing expert classifications and interpretable by experts (i.e., Gene Ontology terms, drug targets, or pathway names); and (4) we manually evaluate in a mini-study how they may be explanatory.

resultsExtracted features reproduce with a good fidelity classifications of drugs causative or not for DILI and SCAR (Accuracy = 0.74 and 0.81, respectively). Experts fully agreed that 73% and 38% of the most discriminative features are possibly explanatory for DILI and SCAR, respectively; and partially agreed (2/3) for 90% and 77% of them.

conclusionKnowledge graphs provide sufficiently diverse features to enable simple and explainable models to distinguish between drugs that are causative or not for ADRs. In addition to explaining classifications, most discriminative features appear to be good candidates for investigating ADR mechanisms further.

Indexed as

Drug-Related Side Effects and Adverse ReactionsPattern Recognition, AutomatedAdverse Drug Reaction Reporting SystemsArtificial IntelligenceFeasibility StudiesHumansPharmacovigilanceAdverse drug reactionData miningExplainable AIExplanationKnowledge graphMachine learningMechanism of actionMolecular mechanism

Identifiers

PMID34039343
PMCPMC8157660
OpenAlexW3164311865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.